Phreesia, Inc.
General ticker "PHR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.5B (TTM average)
Phreesia, Inc. does not follow the US Stock Market performance with the rate: -2.6%.
Estimated limits based on current volatility of 1.7%: low 16.03$, high 16.70$
Factors to consider:
- Total employees count: 2082 (+44.8%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Strategic risks and growth management, Customer satisfaction, Dependency on large customers, Labor/talent shortage/retention
- Current price 17.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [19.85$, 40.11$]
- 2026-01-31 to 2027-01-31 estimated range: [19.66$, 39.71$]
Financial Metrics affecting the PHR estimates:
- Negative: with PPE of -27.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 68.18 > 64.17
- Positive: 0.04 < Operating cash flow per share per price, % of 2.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -4.41 < Investing cash flow per share per price, % of -1.49
Short-term PHR quotes
Long-term PHR plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | $280.91MM | $356.30MM | $419.81MM |
| Operating Expenses | $457.46MM | $492.78MM | $477.91MM |
| Operating Income | $-176.55MM | $-136.48MM | $-58.10MM |
| Non-Operating Income | $0.89MM | $1.14MM | $2.29MM |
| R&D Expense | $91.24MM | $112.35MM | $117.36MM |
| Income(Loss) | $-175.66MM | $-135.34MM | $-55.81MM |
| Taxes | $0.48MM | $1.54MM | $2.72MM |
| Profit(Loss)* | $-176.15MM | $-136.88MM | $-58.53MM |
| Stockholders Equity | $287.82MM | $251.45MM | $264.81MM |
| Inventory | $1.06MM | $0.77MM | $0.00MM |
| Assets | $370.06MM | $370.33MM | $388.42MM |
| Operating Cash Flow | $-90.12MM | $-32.38MM | $32.38MM |
| Capital expenditure | $26.20MM | $25.10MM | $24.09MM |
| Investing Cash Flow | $-26.20MM | $-39.67MM | $-24.09MM |
| Financing Cash Flow | $-20.80MM | $-17.11MM | $-11.49MM |
| Earnings Per Share** | $-3.36 | $-2.51 | $-1.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.